© Copyright 2018 - American Journal of Ophthalmic Clinical Trials - All rights reserved.
Published by Scientific Scholar
ISSN (Print): 2576-1005
ISSN (Online): 2576-1013
The American Journal of Ophthalmic Clinical Trials is an open access peer-reviewed international journal committed to publishing high-quality articles in the field of Ophthalmology. The journal aims to present the most current information in Ophthalmology by summarizing recent clinical trials in light of practice patterns and previous studies. The journal is owned and published by the Scientific Scholar.
Our audience includes Ophthalmologists, Optometrists, Researchers, Clinicians, other medical professionals, and medical students. The goal is to create meaningful summaries on how clinical studies impact the clinical care of patients.
AJOCT has a highly rigorous peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts, affiliations and financial associations such that the published content is not biased.
The editorial board comprises of a panel of experts in ophthalmology considered leaders in their respective subspecialty fields. Our editorial board members provide their expertise and guidance in shaping the content and direction of the journal.
Rishi P. Singh, MD is Editor in Chief of American Journal of Ophthalmic Clinical Trials
Dr. Rishi P. Singh, MD is a staff surgeon at the Cole Eye Institute, Cleveland Clinic and Associate Professor of Ophthalmology at the Lerner College of Medicine in Cleveland Ohio. He also currently serves as the medical director of informatics at the Cleveland Clinic. He received his bachelors and medical degrees from Boston University and completed his residency at the Massachusetts Eye and Infirmary Harvard Combined Program in Boston, Massachusetts. Dr. Singh then completed a medical and surgical fellowship at the Cole Eye Institute in Cleveland, Ohio.
He specializes in the treatment of medical and surgical retinal diseases such as diabetic retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has authored greater than 110 peer-reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease. He is frequently invited to speak at national and international meetings, as well as continuing medical education seminars. Dr. Singh is also a reviewer for various ophthalmology and medical publications including Archives of Ophthalmology, American Journal of Ophthalmology, IOVS, and Ophthalmology. He maintains a strong relationship with drug development and commercial entities by serving on scientific advisory boards. Dr. Singh is the current president on the Retina World Congress and is on the board of the American Society of Retina Specialists.
Dr. Singh’s current work focuses on electronic medical records implementation, lean process improvement, and decision support modules for clinical practice. He operates the Cleveland Clinic Electronic Health Record Consulting program. Dr. Singh has been honored with several research recognitions such as the Alpha Omega Alpha Research Award and the American Society of Retina Specialists Senior Honor Award.
The AJOCT will cover technical and clinical studies related to health, ethical and social issues in the field of ophthalmology. Manuscripts with high clinical interest and implications will be given preference.
The mission of this journal is to publish, promote, educate, and spread the knowledge of ophthalmology in a manner that enables Ophthalmologists to clearly comprehend concepts and practices and encourage further research and technical innovations.
American Journal of Ophthalmic Clinical Trials is a platform for practicing Ophthalmologists, researchers, and students to share, learn, and gain an in-depth understanding of the concepts and practices of Ophthalmology, and to understand the technical advancements within the field. The journal aims to make available cutting edge technical and relevant knowledge to Ophthalmologists leading to optimal healthcare for all. It intends to maintain the highest standard of professionalism to ensure advancement Ophthalmology to the next level.
American Journal of Ophthalmic Clinical Trials will have eight categories covering all sub-specialties of ophthalmology: Comprehesive, Cornea, Glaucoma, Refractive, Plastics, Retina, Uveitis, and Neuro-ophthalmology. The journal publishes original research papers, papers on technical innovations, review articles, innovations, pictorial essays, case reports, case series and letters to editors. The journal allows free access to its articles.
Many journals consider case reports to have a low impact factor. If done correctly, case reports can be the basic building blocks of medical knowledge in Ophthalmology. We strongly encourage authors to send case reports for publication in our journal. We believe case reports stimulate the reader’s thought processes and encourage them to think of novel and varied paths. This, in turn, results in the generation of new research ideas and is very important in promoting scientific investigation and exploration.
It is a peer-reviewed international journal with a double-blind review process. Its frequency of publication is continuous, what that means is, it publishes the article once it’s accepted after peer review. Currently, we only have E-Journal and do not publish in print.
An article published in the journal can be viewed without a fee by readers all over the world. The author also gets to retain copyright to the article and the figures. This allows authors to extend their exposure in the world of medical research and get worldwide recognition for their work.
The journal will be registered with the following abstracting partners:EBSCO Publishing’s Electronic Databases, Google Scholar, Crossref, Open Academic Journals Index (OAJI), Directory of Research Journals Indexing (DRJI), Eurasian Scientific Journal Index, Scientific Indexing Services (SIS) and Index Copernicus International World of Journals (ICI), International Committee of Medical Journal Editors (ICMJE).
The American Journal of Ophthalmic Clinical Trials is committed to meeting and upholding the standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit our Ethical Guidelines section
We have plagiarism check available on our Editors and Reviewer’s panel in the manuscript management system. We encourage our editors and reviewers to use the plagiarism check. Any manuscript with plagiarism will be rejected immediately.
This is an open-access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. American Journal of Ophthalmic Clinical Trials has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content are not biased or influenced by the advertisement.
“Pop-up” and “banner” advertisement appears at a fixed location on the page and does not interfere with the manuscript in any form.
The Editorial Board has full and final approval over the content of all advertisements.
Advertisers will never be shown any manuscripts or other content prior to publication.
Scientific Scholar, USA, established with the aim of publishing scientific journals. The mission of the company is “Share, Learn and Improve”.
Beginning in 2017, scientific journal publishing bought under the new umbrella of “Scientific Scholar”.
Imaging Science Today was founded in 2011 by a group of practicing doctors and industry specialists. It is a well-respected medical publisher that fully supports many of the popular open access models and all the aspects of the scientific journal publishing through its peer-review management system – Scientific Scholar and Open Access platform. The headquarter of Scientific Scholar is in Rochester, NY, USA and has a subsidiary arm in India.